DF
Therapeutic Areas
Nextcea Pipeline
| Drug | Indication | Phase |
|---|---|---|
| LRRK2 Biomarker Services | Parkinson's Disease | Service Offering |
| GBA Biomarker Services | Parkinson's Disease & Gaucher Disease | Service Offering |
| BTK Biomarker Services | Leukemia / Lymphoma | Service Offering |
| Phospholipidosis & Kidney Safety Assessment | Drug-Induced Toxicity (e.g., Parkinsonism) | Service Offering |